‘On-demand’ sessions from Broadcast 3 of the 2021 Primary Care Issues & Answers Live Inaugural Broadcasts – Long Covid: The way ahead. Includes supporting slide sets and factsheets.
Long Covid: Broadcast 3
Long Covid: Broadcast 2
‘On-demand’ sessions from Broadcast 2 of the 2021 Primary Care Issues & Answers Live Inaugural Broadcasts – Long Covid: The way ahead. Includes supporting slide sets and factsheets.
ABC of CVD: What primary care need to know
Beverley Bostock takes us through the ABC of cardiovascular disease – Atrial fibrillation, blood pressure and cholesterol.
GLP-1 (3/3): Translating theory into practice. An interactive case-based discussion
Su Down and Dr Kevin Fernando translate the theory into practice with case based discussion covering glucose management and initiating GLP-1 RA for CV benefit.
Heart Failure – The new standard of care
Dr Yassir Javaid discusses the modern management of heart failure from a cardiovascular perspective.
GLP-1 (2/3): Practicalities of starting GLP-1 receptor agonist therapy
Jane Diggle and Nicola Milne discuss GLP-1 Receptor Agonists so you can enhance your knowledge and gain confidence in the practicalities of initiating GLP-1 receptor agonists effectively in daily practice.
GLP-1 (1/3): Understanding the incretin effect and GLP-1 receptor agonist therapy
Jane Diggle and her expert colleagues will discuss GLP-1 Receptor Agonists including ‘Understanding the Incretin effect and GLP-1 Receptor Agonist Therapy’ by Professor Michael Cummings.
SGLT2 (3/5) – SGLT2 inhibitors and the kidney
Professor Cliff Bailey and Dr Pam Brown discuss the Reno-protective effects of SGLT2 inhibitors and the role of SGLT2 inhibitors in the management of diabetic kidney disease.
SGLT2 (2/5) – SGLT2 inhibitors and the heart
Professor Cliff Bailey and Dr Martin Hadley-Brown discuss the effects of SGLT2 inhibitors on cardiovascular function and the role of SGLT2 inhibitors in the management of CV disease.
SGLT2 (1/5) – Understanding SGLT2 inhibition
Professor Cliff Bailey and Professor Vinod Patel assess the clinical evidence and opportunities offered by sodium-glucose co-transporter-2 (SGLT2) inhibitors in the management of type 2 diabetes and its cardio-renal complications.
Three ages of syncope; syncope in children, pregnancy and the elderly
Dr Kavi will discuss common causes of syncope in children, briefly covering reflex anoxic seizures, vasovagal syncope, postural tachycardia syndrome and syncope in young athletes. The causes and implications of syncope during pregnancy will be described. The final part of the talk will consider the relationship between syncope and falls in older people.
Preventing and managing cardiovascular disease in a virtual setting – a practical approach
Preventing and Managing Cardiovascular Disease in a virtual setting – a practical approach, with Dr Jim Moore and Beverley Bostock.
